Specify a stock or a cryptocurrency in the search bar to get a summary
Healius Ltd
HLSHealius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia. Address: 161 Castlereagh Street, Sydney, NSW, Australia, 2000
Analytics
WallStreet Target Price
2.41 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures HLS
Dividend Analytics HLS
Dividend growth over 5 years
–Continuous growth
2 yearsPayout Ratio 5 years average
61 %Dividend History HLS
Stock Valuation HLS
Financials HLS
Results | 2019 | Dynamics |